Insider Transactions in Q2 2022 at Fusion Pharmaceuticals Inc. (FUSN)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 27
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,511
-1.4%
|
$27,066
$6.03 P/Share
|
Apr 26
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,147
-0.66%
|
$12,882
$6.07 P/Share
|
Apr 25
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,036
-0.62%
|
$12,216
$6.03 P/Share
|
Apr 21
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
922
-0.28%
|
$5,532
$6.01 P/Share
|
Apr 20
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
367
-0.11%
|
$2,202
$6.02 P/Share
|
Apr 13
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,994
-3.53%
|
$71,964
$6.41 P/Share
|
Apr 12
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,255
-5.09%
|
$127,785
$7.1 P/Share
|
Apr 11
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,600
-0.72%
|
$18,200
$7.37 P/Share
|
Apr 08
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
826
-0.23%
|
$5,782
$7.52 P/Share
|
Apr 07
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,255
-0.35%
|
$8,785
$7.56 P/Share
|
Apr 06
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$700
$7.58 P/Share
|
Apr 05
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.57%
|
$14,700
$7.67 P/Share
|
Apr 04
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
700
-0.19%
|
$4,900
$7.81 P/Share
|
Apr 01
2022
|
John Valliant Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$7,000
$7.75 P/Share
|